Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 635

1.

Deep dense multi-path neural network for prostate segmentation in magnetic resonance imaging.

To MNN, Vu DQ, Turkbey B, Choyke PL, Kwak JT.

Int J Comput Assist Radiol Surg. 2018 Aug 7. doi: 10.1007/s11548-018-1841-4. [Epub ahead of print]

PMID:
30088208
2.

Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: The Role of a Negative Confirmatory MRI-US Fusion Biopsy.

Bloom JB, Hale G, Gold SA, Rayn K, Smith C, Mehralivand S, Czarniecki M, Valera V, Wood BJ, Merino M, Choyke PL, Parnes HL, Turkbey B, Pinto PA.

J Urol. 2018 Jul 28. pii: S0022-5347(18)43606-3. doi: 10.1016/j.juro.2018.07.051. [Epub ahead of print]

PMID:
30063928
3.

Quantitative MRI or Machine Learning for Prostate MRI: Which Should You Use?

Choyke PL.

Radiology. 2018 Jul 31:181304. doi: 10.1148/radiol.2018181304. [Epub ahead of print] No abstract available.

PMID:
30063185
4.

68Ga-PSMA-11 PET/CT in Primary and Recurrent Prostate Carcinoma: Implications for Radiotherapeutic Management in 121 Patients.

Koerber SA, Will L, Kratochwil C, Haefner MF, Rathke H, Kremer C, Merkle J, Herfarth K, Kopka K, Choyke PL, Holland-Letz T, Haberkorn U, Debus J, Giesel FL.

J Nucl Med. 2018 Jul 5. pii: jnumed.118.211086. doi: 10.2967/jnumed.118.211086. [Epub ahead of print]

PMID:
29976697
5.

Comparison of Elastic and Rigid Registration During Magnetic Resonance Imaging/Ultrasound Fusion-Guided Prostate Biopsy: A Multi-Operator Phantom Study.

Hale GR, Czarniecki M, Cheng A, Bloom JB, Seifabadi R, Gold SA, Rayn KN, Sabarwal VK, Mehralivand S, Choyke PL, Turkbey B, Wood B, Pinto PA.

J Urol. 2018 Jun 22. pii: S0022-5347(18)43407-6. doi: 10.1016/j.juro.2018.06.028. [Epub ahead of print]

PMID:
29940248
6.

One-pot synthesis and biodistribution of fluorine-18 labeled serum albumin for vascular imaging.

Basuli F, Zhang X, Williams MR, Seidel J, Green MV, Choyke PL, Swenson RE, Jagoda EM.

Nucl Med Biol. 2018 Jul - Aug;62-63:63-70. doi: 10.1016/j.nucmedbio.2018.05.004. Epub 2018 May 30.

PMID:
29929114
7.

Radiomics and radiogenomics of prostate cancer.

Smith CP, Czarniecki M, Mehralivand S, Stoyanova R, Choyke PL, Harmon S, Turkbey B.

Abdom Radiol (NY). 2018 Jun 20. doi: 10.1007/s00261-018-1660-7. [Epub ahead of print]

PMID:
29926137
8.

Validation of PI-RADS Version 2 in Transition Zone Lesions for the Detection of Prostate Cancer.

Thai JN, Narayanan HA, George AK, Siddiqui MM, Shah P, Mertan FV, Merino MJ, Pinto PA, Choyke PL, Wood BJ, Turkbey B.

Radiology. 2018 Aug;288(2):485-491. doi: 10.1148/radiol.2018170425. Epub 2018 May 22.

PMID:
29786491
9.

Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?

Gold SA, Hale GR, Bloom JB, Smith CP, Rayn KN, Valera V, Wood BJ, Choyke PL, Turkbey B, Pinto PA.

World J Urol. 2018 May 21. doi: 10.1007/s00345-018-2337-0. [Epub ahead of print]

PMID:
29785491
10.

Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis.

Sidana A, Watson MJ, George AK, Rastinehad AR, Vourganti S, Rais-Bahrami S, Muthigi A, Maruf M, Gordetsky JB, Nix JW, Merino MJ, Turkbey B, Choyke PL, Wood BJ, Pinto PA.

Urol Oncol. 2018 Jul;36(7):341.e1-341.e7. doi: 10.1016/j.urolonc.2018.04.002. Epub 2018 May 10.

PMID:
29753548
11.

Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?

An JY, Harmon SA, Mehralivand S, Czarniecki M, Smith CP, Peretti JA, Wood BJ, Pinto PA, Choyke PL, Shih JH, Turkbey B.

Abdom Radiol (NY). 2018 May 11. doi: 10.1007/s00261-018-1631-z. [Epub ahead of print]

PMID:
29752491
12.

Can Apparent Diffusion Coefficient Values Assist PI-RADS Version 2 DWI Scoring? A Correlation Study Using the PI-RADSv2 and International Society of Urological Pathology Systems.

Gaur S, Harmon S, Rosenblum L, Greer MD, Mehralivand S, Coskun M, Merino MJ, Wood BJ, Shih JH, Pinto PA, Choyke PL, Turkbey B.

AJR Am J Roentgenol. 2018 Jul;211(1):W33-W41. doi: 10.2214/AJR.17.18702. Epub 2018 May 7.

PMID:
29733695
13.

Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody.

Nagaya T, Okuyama S, Ogata F, Maruoka Y, Knapp DW, Karagiannis SN, Fazekas-Singer J, Choyke PL, LeBlanc AK, Jensen-Jarolim E, Kobayashi H.

Oncotarget. 2018 Apr 10;9(27):19026-19038. doi: 10.18632/oncotarget.24876. eCollection 2018 Apr 10.

14.

A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).

Gaur S, Harmon S, Gupta RT, Margolis DJ, Lay N, Mehralivand S, Merino MJ, Wood BJ, Pinto PA, Shih JH, Choyke PL, Turkbey B.

Acad Radiol. 2018 Apr 25. pii: S1076-6332(18)30137-5. doi: 10.1016/j.acra.2018.03.024. [Epub ahead of print]

PMID:
29705281
15.

Endoscopic near infrared photoimmunotherapy using a fiber optic diffuser for peritoneal dissemination of gastric cancer.

Nagaya T, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Kobayashi H.

Cancer Sci. 2018 Jun;109(6):1902-1908. doi: 10.1111/cas.13621. Epub 2018 May 29.

16.

Andrew Joseph Dwyer, MD.

Choyke PL, Jones EC, Kim L.

Radiology. 2018 Jun;287(3):E1. doi: 10.1148/radiol.2018184009. Epub 2018 Apr 18. No abstract available.

PMID:
29668356
17.

Computer-aided diagnosis prior to conventional interpretation of prostate mpMRI: an international multi-reader study.

Greer MD, Lay N, Shih JH, Barrett T, Bittencourt LK, Borofsky S, Kabakus I, Law YM, Marko J, Shebel H, Mertan FV, Merino MJ, Wood BJ, Pinto PA, Summers RM, Choyke PL, Turkbey B.

Eur Radiol. 2018 Apr 12. doi: 10.1007/s00330-018-5374-6. [Epub ahead of print]

PMID:
29651763
18.

Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer.

Gaur S, Harmon S, Mehralivand S, Bednarova S, Calio BP, Sugano D, Sidana A, Merino MJ, Pinto PA, Wood BJ, Shih JH, Choyke PL, Turkbey B.

J Magn Reson Imaging. 2018 Mar 31. doi: 10.1002/jmri.26025. [Epub ahead of print]

PMID:
29603833
19.

A Prospective Comparison of 18F-Sodium Fluoride PET/CT and PSMA-targeted 18F-DCFBC PET/CT in Metastatic Prostate Cancer.

Harmon SA, Bergvall E, Mena E, Shih JH, Adler S, McKinney Y, Mehralivand S, Citrin DE, Couvillon A, Madan R, Gulley J, Mease RC, Jacobs PM, Pomper MG, Turkbey B, Choyke PL, Lindenberg ML.

J Nucl Med. 2018 Mar 30. pii: jnumed.117.207373. doi: 10.2967/jnumed.117.207373. [Epub ahead of print]

PMID:
29602821
20.

Rapid synthesis of maleimide functionalized fluorine-18 labeled prosthetic group using "radio-fluorination on the Sep-Pak" method.

Basuli F, Zhang X, Jagoda EM, Choyke PL, Swenson RE.

J Labelled Comp Radiopharm. 2018 Jun 30;61(8):599-605. doi: 10.1002/jlcr.3623. Epub 2018 May 1.

PMID:
29575176
21.

Imaging findings of hereditary renal tumors, a review of what the radiologist should know.

Czarniecki M, Gautam R, Choyke PL, Turkbey B.

Eur J Radiol. 2018 Apr;101:8-16. doi: 10.1016/j.ejrad.2018.01.026. Epub 2018 Feb 2. Review.

PMID:
29571805
22.

Imaging the High-risk Prostate Cancer Patient: Current and Future Approaches to Staging.

Bjurlin MA, Turkbey B, Rosenkrantz AB, Gaur S, Choyke PL, Taneja SS.

Urology. 2018 Jun;116:3-12. doi: 10.1016/j.urology.2017.12.001. Epub 2018 Mar 12. Review.

PMID:
29545055
23.

Interstitial near-infrared photoimmunotherapy: effective treatment areas and light doses needed for use with fiber optic diffusers.

Okuyama S, Nagaya T, Sato K, Ogata F, Maruoka Y, Choyke PL, Kobayashi H.

Oncotarget. 2018 Jan 27;9(13):11159-11169. doi: 10.18632/oncotarget.24329. eCollection 2018 Feb 16.

24.

A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk Stratification.

Mehralivand S, Shih JH, Rais-Bahrami S, Oto A, Bednarova S, Nix JW, Thomas JV, Gordetsky JB, Gaur S, Harmon SA, Siddiqui MM, Merino MJ, Parnes HL, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

JAMA Oncol. 2018 May 1;4(5):678-685. doi: 10.1001/jamaoncol.2017.5667.

PMID:
29470570
25.

Advances in prostate-specific membrane antigen PET of prostate cancer.

Bouchelouche K, Choyke PL.

Curr Opin Oncol. 2018 May;30(3):189-196. doi: 10.1097/CCO.0000000000000439.

PMID:
29465429
26.

Near Infrared Photoimmunotherapy with Combined Exposure of External and Interstitial Light Sources.

Maruoka Y, Nagaya T, Sato K, Ogata F, Okuyama S, Choyke PL, Kobayashi H.

Mol Pharm. 2018 Feb 21. doi: 10.1021/acs.molpharmaceut.8b00002. [Epub ahead of print]

PMID:
29450993
27.

Future Perspectives and Challenges of Prostate MR Imaging.

Turkbey B, Choyke PL.

Radiol Clin North Am. 2018 Mar;56(2):327-337. doi: 10.1016/j.rcl.2017.10.013. Epub 2017 Dec 9. Review.

PMID:
29420986
28.

Avoiding thermal injury during near-infrared photoimmunotherapy (NIR-PIT): the importance of NIR light power density.

Okuyama S, Nagaya T, Ogata F, Maruoka Y, Sato K, Nakamura Y, Choyke PL, Kobayashi H.

Oncotarget. 2017 Aug 11;8(68):113194-113201. doi: 10.18632/oncotarget.20179. eCollection 2017 Dec 22.

29.

All over the map: An interobserver agreement study of tumor location based on the PI-RADSv2 sector map.

Greer MD, Shih JH, Barrett T, Bednarova S, Kabakus I, Law YM, Shebel H, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

J Magn Reson Imaging. 2018 Jan 17. doi: 10.1002/jmri.25948. [Epub ahead of print]

PMID:
29341356
30.

Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy.

Valle LF, Greer MD, Shih JH, Barrett T, Law YM, Rosenkrantz AB, Shebel H, Muthigi A, Su D, Merino MJ, Wood BJ, Pinto PA, Krauze AV, Kaushal A, Choyke PL, Türkbey B, Citrin DE.

Diagn Interv Radiol. 2018 Jan-Feb;24(1):46-53. doi: 10.5152/dir.2018.17285.

31.

Fluorescence-Guided Surgery.

Nagaya T, Nakamura YA, Choyke PL, Kobayashi H.

Front Oncol. 2017 Dec 22;7:314. doi: 10.3389/fonc.2017.00314. eCollection 2017. Review.

32.

Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes.

Kishimoto S, Oshima N, Yamamoto K, Munasinghe J, Ardenkjaer-Larsen JH, Mitchell JB, Choyke PL, Krishna MC.

Free Radic Biol Med. 2018 Feb 20;116:1-10. doi: 10.1016/j.freeradbiomed.2017.12.034. Epub 2017 Dec 29.

PMID:
29289705
33.

Dynamic changes in the cell membrane on three dimensional low coherent quantitative phase microscopy (3D LC-QPM) after treatment with the near infrared photoimmunotherapy.

Ogata F, Nagaya T, Okuyama S, Maruoka Y, Choyke PL, Yamauchi T, Kobayashi H.

Oncotarget. 2017 Nov 1;8(61):104295-104302. doi: 10.18632/oncotarget.22223. eCollection 2017 Nov 28.

34.

Activatable fluorescent probes in fluorescence-guided surgery: Practical considerations.

Mochida A, Ogata F, Nagaya T, Choyke PL, Kobayashi H.

Bioorg Med Chem. 2018 Feb 15;26(4):925-930. doi: 10.1016/j.bmc.2017.12.002. Epub 2017 Dec 5. Review.

PMID:
29242021
35.

Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate.

Nagaya T, Gorka AP, Nani RR, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Schnermann MJ, Kobayashi H.

Mol Cancer Ther. 2018 Mar;17(3):661-670. doi: 10.1158/1535-7163.MCT-17-0851. Epub 2017 Dec 13.

PMID:
29237807
36.

Functional and Targeted Lymph Node Imaging in Prostate Cancer: Current Status and Future Challenges.

Thoeny HC, Barbieri S, Froehlich JM, Turkbey B, Choyke PL.

Radiology. 2017 Dec;285(3):728-743. doi: 10.1148/radiol.2017161517. Review.

PMID:
29155624
37.

Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology-Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help?

Calio BP, Sidana A, Sugano D, Gaur S, Maruf M, Jain AL, Merino MJ, Choyke PL, Wood BJ, Pinto PA, Turkbey B.

J Urol. 2018 Apr;199(4):976-982. doi: 10.1016/j.juro.2017.10.048. Epub 2018 Jan 20.

PMID:
29154904
38.

Ruling out clinically significant prostate cancer with negative multi-parametric MRI.

An JY, Sidana A, Holzman SA, Baiocco JA, Mehralivand S, Choyke PL, Wood BJ, Turkbey B, Pinto PA.

Int Urol Nephrol. 2018 Jan;50(1):7-12. doi: 10.1007/s11255-017-1715-7. Epub 2017 Nov 15.

PMID:
29143253
39.

Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.

Maruoka Y, Nagaya T, Nakamura Y, Sato K, Ogata F, Okuyama S, Choyke PL, Kobayashi H.

Mol Pharm. 2017 Dec 4;14(12):4628-4635. doi: 10.1021/acs.molpharmaceut.7b00731. Epub 2017 Nov 22.

PMID:
29135265
40.

Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET.

Weiss ID, Huff LM, Evbuomwan MO, Xu X, Dang HD, Velez DS, Singh SP, Zhang HH, Gardina PJ, Lee JH, Lindenberg L, Myers TG, Paik CH, Schrump DS, Pittaluga S, Choyke PL, Fojo T, Farber JM.

Oncotarget. 2017 Aug 4;8(43):73387-73406. doi: 10.18632/oncotarget.19945. eCollection 2017 Sep 26.

41.

What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate.

Borofsky S, George AK, Gaur S, Bernardo M, Greer MD, Mertan FV, Taffel M, Moreno V, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

Radiology. 2018 Jan;286(1):186-195. doi: 10.1148/radiol.2017152877. Epub 2017 Oct 20.

PMID:
29053402
42.

The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer.

Verma S, Choyke PL, Eberhardt SC, Oto A, Tempany CM, Turkbey B, Rosenkrantz AB.

Radiology. 2017 Nov;285(2):343-356. doi: 10.1148/radiol.2017161684. Review.

PMID:
29045233
43.

Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer.

An JY, Sidana A, Choyke PL, Wood BJ, Pinto PA, Türkbey İB.

Balkan Med J. 2017 Sep 29;34(5):388-396. doi: 10.4274/balkanmedj.2017.0708.

44.

The ABCs of BHD: An In-Depth Review of Birt-Hogg-Dubé Syndrome.

Gupta S, Kang HC, Ganeshan D, Morani A, Gautam R, Choyke PL, Kundra V.

AJR Am J Roentgenol. 2017 Dec;209(6):1291-1296. doi: 10.2214/AJR.17.18071. Epub 2017 Oct 5. Review.

PMID:
28981362
45.

Characteristics of ovarian cancer detection by a near-infrared fluorescent probe activated by human NAD(P)H: quinone oxidoreductase isozyme 1 (hNQO1).

Nakamura Y, Shen Z, Harada T, Nagaya T, Sato K, Okuyama S, Ogata F, Choyke PL, McCarley RL, Kobayashi H.

Oncotarget. 2017 May 20;8(37):61181-61192. doi: 10.18632/oncotarget.18044. eCollection 2017 Sep 22.

46.

Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT.

Nagaya T, Nakamura Y, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Allen C, Kobayashi H.

Mol Cancer Res. 2017 Dec;15(12):1667-1677. doi: 10.1158/1541-7786.MCR-17-0333. Epub 2017 Sep 18.

PMID:
28923838
47.

Clinical impact of PSMA-based 18F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy.

Mena E, Lindenberg ML, Shih JH, Adler S, Harmon S, Bergvall E, Citrin D, Dahut W, Ton AT, McKinney Y, Weaver J, Eclarinal P, Forest A, Afari G, Bhattacharyya S, Mease RC, Merino MJ, Pinto P, Wood BJ, Jacobs P, Pomper MG, Choyke PL, Turkbey B.

Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):4-11. doi: 10.1007/s00259-017-3818-x. Epub 2017 Sep 11.

PMID:
28894899
48.

18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology.

Turkbey B, Mena E, Lindenberg L, Adler S, Bednarova S, Berman R, Ton AT, McKinney Y, Eclarinal P, Hill C, Afari G, Bhattacharyya S, Mease RC, Merino MJ, Jacobs PM, Wood BJ, Pinto PA, Pomper MG, Choyke PL.

Clin Nucl Med. 2017 Oct;42(10):735-740. doi: 10.1097/RLU.0000000000001804.

PMID:
28806263
49.

Comparison of planar, PET and well-counter measurements of total tumor radioactivity in a mouse xenograft model.

Green MV, Seidel J, Williams MR, Wong KJ, Ton A, Basuli F, Choyke PL, Jagoda EM.

Nucl Med Biol. 2017 Oct;53:29-36. doi: 10.1016/j.nucmedbio.2017.06.004. Epub 2017 Jun 30.

PMID:
28797928
50.

Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2.

Greer MD, Shih JH, Lay N, Barrett T, Kayat Bittencourt L, Borofsky S, Kabakus IM, Law YM, Marko J, Shebel H, Mertan FV, Merino MJ, Wood BJ, Pinto PA, Summers RM, Choyke PL, Turkbey B.

Radiology. 2017 Dec;285(3):859-869. doi: 10.1148/radiol.2017161316. Epub 2017 Jul 19.

PMID:
28727501

Supplemental Content

Loading ...
Support Center